Cite
Ranieri G, Laface C, Laforgia M, et al. Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study. Front Oncol. 2020;10:590707doi: 10.3389/fonc.2020.590707.
Ranieri, G., Laface, C., Laforgia, M., De Summa, S., Porcelli, M., Macina, F., Ammendola, M., Molinari, P., Lauletta, G., Di Palo, A., Rubini, G., Ferrari, C., & Gadaleta, C. D. (2020). Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study. Frontiers in oncology, 10590707. https://doi.org/10.3389/fonc.2020.590707
Ranieri, Girolamo, et al. "Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study." Frontiers in oncology vol. 10 (2020): 590707. doi: https://doi.org/10.3389/fonc.2020.590707
Ranieri G, Laface C, Laforgia M, De Summa S, Porcelli M, Macina F, Ammendola M, Molinari P, Lauletta G, Di Palo A, Rubini G, Ferrari C, Gadaleta CD. Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study. Front Oncol. 2020 Nov 03;10:590707. doi: 10.3389/fonc.2020.590707. eCollection 2020. PMID: 33224885; PMCID: PMC7670056.
Copy
Download .nbib